APA (7th ed.) Citation

Wang, L., Zhao, P., Liu, J., An, Z., Fu, H., Wang, C., . . . Chang, Y. (2025). Peritransplant lysine methyltransferase 2a–rearranged measurable residual disease dynamics as a prognostic marker in adult acute myeloid leukemia. Cancer (0008543X), 131(16), 1. https://doi.org/10.1002/cncr.70044

Chicago Style (17th ed.) Citation

Wang, Lu‐Lu, et al. "Peritransplant Lysine Methyltransferase 2a–rearranged Measurable Residual Disease Dynamics as a Prognostic Marker in Adult Acute Myeloid Leukemia." Cancer (0008543X) 131, no. 16 (2025): 1. https://doi.org/10.1002/cncr.70044.

MLA (9th ed.) Citation

Wang, Lu‐Lu, et al. "Peritransplant Lysine Methyltransferase 2a–rearranged Measurable Residual Disease Dynamics as a Prognostic Marker in Adult Acute Myeloid Leukemia." Cancer (0008543X), vol. 131, no. 16, 2025, p. 1, https://doi.org/10.1002/cncr.70044.